| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 静注丙球(元) | 844,541,322.91 | 470,703,765.76 | 775,072,203.95 | 339,028,963.31 |
| 流感疫苗(元) | 2,402,643,148.24 | 148,147,883.90 | 1,817,533,570.67 | 1,055,583,557.66 |
| 人血白蛋白(元) | 1,056,835,058.45 | 515,356,048.07 | 987,958,361.67 | 474,777,255.49 |
| 其他主营业务(元) | - | - | - | 12,681,032.12 |
| 其他血液制品(元) | 1,024,956,429.63 | 444,712,620.71 | 916,209,701.91 | 467,332,491.15 |
| 其他(元) | 12,896,598.23 | 6,321,598.25 | 20,205,569.86 | 12,681,032.12 |
| 营业成本(元) | ||||
| 静注丙球(元) | 390,642,279.33 | 205,148,934.59 | 371,926,657.17 | 162,906,374.59 |
| 流感疫苗(元) | 281,332,927.75 | -2,983,410.35 | 209,162,851.78 | 119,205,457.03 |
| 人血白蛋白(元) | 452,915,534.72 | 244,829,209.04 | 495,784,620.78 | 234,081,530.53 |
| 其他主营业务(元) | - | - | - | 29,937,277.31 |
| 其他血液制品(元) | 492,551,618.70 | 212,186,304.86 | 410,201,168.52 | 211,047,059.79 |
| 其他(元) | 427,333,521.67 | -19,916,629.87 | 45,790,158.76 | 29,937,277.31 |
| 毛利(元) | ||||
| 静注丙球(元) | 453,899,043.58 | 265,554,831.17 | 403,145,546.78 | 176,122,588.72 |
| 流感疫苗(元) | 2,121,310,220.49 | 151,131,294.25 | 1,608,370,718.89 | 936,378,100.63 |
| 人血白蛋白(元) | 603,919,523.73 | 270,526,839.03 | 492,173,740.89 | 240,695,724.96 |
| 其他主营业务(元) | - | - | - | -17,256,245.19 |
| 其他血液制品(元) | 532,404,810.93 | 232,526,315.85 | 506,008,533.39 | 256,285,431.36 |
| 其他(元) | -414,436,923.44 | 26,238,228.12 | -25,584,588.90 | -17,256,245.19 |
| 毛利率(%) | ||||
| 静注丙球(%) | 53.75 | 56.42 | 52.01 | 51.95 |
| 流感疫苗(%) | 88.29 | 102.01 | 88.49 | 88.71 |
| 人血白蛋白(%) | 57.14 | 52.49 | 49.82 | 50.70 |
| 其他主营业务(%) | - | - | - | -136.08 |
| 其他血液制品(%) | 51.94 | 52.29 | 55.23 | 54.84 |
| 其他(%) | -3,213.54 | 415.06 | -126.62 | -136.08 |
| 收入构成(%) | ||||
| 静注丙球(%) | 15.81 | 29.69 | 17.16 | 14.35 |
| 流感疫苗(%) | 44.98 | 9.35 | 40.24 | 44.69 |
| 人血白蛋白(%) | 19.78 | 32.51 | 21.87 | 20.10 |
| 其他主营业务(%) | - | - | - | 0.54 |
| 其他血液制品(%) | 19.19 | 28.05 | 20.28 | 19.78 |
| 其他(%) | 0.24 | 0.40 | 0.45 | 0.54 |
| 毛利构成(%) | ||||
| 静注丙球(%) | 13.77 | 28.07 | 13.51 | 11.18 |
| 流感疫苗(%) | 64.34 | 15.98 | 53.90 | 59.45 |
| 人血白蛋白(%) | 18.32 | 28.60 | 16.49 | 15.28 |
| 其他主营业务(%) | - | - | - | -1.10 |
| 其他血液制品(%) | 16.15 | 24.58 | 16.96 | 16.27 |
| 其他(%) | -12.57 | 2.77 | -0.86 | -1.10 |